Novavax stock rises more than 20% after the study of the COVID-19 vaccine shows almost 90% effectiveness in the UK, but less against the new South African variant
As the EU fights the shortage of AstraZeneca, the United Kingdom continues to manufacture the new vaccine COVID
Pfizer Covid-19 vaccine works against mutations found in the UK, South Africa variants, laboratory study results
Commercial frenzy with AMC shares may avoid bankruptcy, but cinema operator still faces years of recovery